Small Cell Lung Cancer

Patients with an advanced form of lung cancer lived 56 percent longer without their disease progressing when radiotherapy…

Chronic exposure to cigarette smoke may reprogram different populations of lung stem cells, which maintain and repair lung…

Adding local consolidative therapy (LCT) after induction treatment with nivolumab plus ipilimumab did not improve overall survival or…

The advent of mRNA vaccines against SARS-CoV-2 in 2020 changed the course of the COVID-19 pandemic. Now, the…

Breakthrough research presented at the 2026 Society of Thoracic Surgeons Annual Meeting shows that additional lymph node evaluation…

Small cell lung cancer (SCLC) is one of the most aggressive forms of lung cancer, with a five-year…

Lung cancer is the second-most common cancer and the leading cause of cancer death in the United States.…

A new study reveals that SARS-CoV-2 mRNA vaccines can amplify immune checkpoint therapy in lung and skin cancers…

Interim results from the NADIM ADJUVANT Phase III trial, led by the Spanish Lung Cancer Group (GECP), suggest…

Patients with a form of advanced lung cancer lived 56 percent longer without their disease progressing after receiving radiotherapy in addition to standard treatment